The overexpression of the epidermal growth factor receptor (EGFR) and the protein, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 (ErbB2), have been reported to be involved in cancer progression and development, including prostate cancer [23]. This evidence concerns the gene EGFR and prostate carcinoma.